1-4 of 4
C Shustik
Close
Sort by
Journal Articles

A National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) Phase II Study of Oral Fludarabine in Untreated B-Cell Chronic Lymphocytic Leukemia.

C. Shustik, R. Turner, P. Desjardins, L. Fernandez, S. Rubin, L. Larratt, A. Duncan, D. Rizi, A. Sadura, L. Shepherd, D. Li, L. Rassenti, T. Kipps
Journal: Blood
Blood (2005) 106 (11): 2977.
https://doi.org/10.1182/blood.V106.11.2977.2977
Published: 2005
Journal Articles

Multiple Myeloma (MM) in Young Patients (pts): Clinical Features and Outcome in 259 Patients Younger Than 40 Years in Comparison to 8,296 pts Aged ≥ 40 Years.

Heinz Ludwig, B. Durie, V. Bolejack, A. Hoering, M. Dimopoulos, R. Kyle, R. Fonseca, M. Beksac, J. San Miguel, J. Crowley, J. Blade, M. Boccadoro, H. Avet Loiseau, G. Morgan, K. Shimizu, C. Shustik, P. Sonneveld, P. Tosi, I. Turesson, J. Westin
Journal: Blood
Blood (2005) 106 (11): 3414.
https://doi.org/10.1182/blood.V106.11.3414.3414
Published: 2005
Journal Articles

Lack of Response to Short-Term Use of Clarithromycin (BIAXIN) in Multiple Myeloma

A.K. Stewart, S. Trudel, B.M. Al-Berouti, D.M. Sutton, J. Meharchand, C. Shustik
Journal: Blood
Blood (1999) 93 (12): 4441–4442.
https://doi.org/10.1182/blood.V93.12.4441
Published: 1999
Journal Articles

Kappa and lambda light chain disease: survival rates and clinical manifestations

C Shustik, DE Bergsagel, W Pruzanski
Journal: Blood
Blood (1976) 48 (1): 41–51.
https://doi.org/10.1182/blood.V48.1.41.41
Published: 1976